Medications for Herpes Simplex
About Herpes Simplex: An infection caused by herpes viruses 1 or 2 -- which primarily affects the mouth or genital area.
Drugs Used for Herpes Simplex
The following list of medications are in some way related to, or used in the treatment of this condition.
Drug name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
---|---|---|---|---|---|---|---|
acyclovir | B | N | 64 reviews |
8.0
|
|||
Generic name: acyclovir systemic Brand name: Zovirax Drug class: purine nucleosides For consumers: dosage, interactions, For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information |
|||||||
Zovirax Cream | B | N | 3 reviews |
9.0
|
|||
Generic name: acyclovir topical Drug class: topical antivirals For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Abreva | N | N | 240 reviews |
5.0
|
|||
Generic name: docosanol topical Drug class: topical anti-infectives For consumers: dosage, side effects For professionals: AHFS DI Monograph |
|||||||
Zovirax Ointment | B | N | 2 reviews |
8.0
|
|||
Generic name: acyclovir topical Drug class: topical antivirals For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
acyclovir | B | N | 9 reviews |
8.0
|
|||
Generic name: acyclovir topical Brand names: Zovirax Cream, Zovirax Ointment Drug class: topical antivirals For consumers: dosage, interactions, For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information |
|||||||
docosanol | N | N | 250 reviews |
5.0
|
|||
Generic name: docosanol topical Brand name: Abreva Drug class: topical anti-infectives For consumers: dosage, For professionals: AHFS DI Monograph |
|||||||
Zovirax | B | N | 7 reviews |
8.0
|
|||
Generic name: acyclovir systemic Drug class: purine nucleosides For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
Blistex | N | N | 2 reviews |
6.0
|
|||
Generic name: allantoin / camphor / phenol topical Drug class: miscellaneous topical agents For consumers: side effects |
|||||||
allantoin / camphor / phenol | N | N | 2 reviews |
6.0
|
|||
Generic name: allantoin / camphor / phenol topical Brand name: Blistex Drug class: miscellaneous topical agents For consumers: |
|||||||
Topics under Herpes Simplex
- Cold Sores (22 drugs)
- Herpes Simplex - Congenital (2 drugs)
- Herpes Simplex Otitis Externa (0 drugs)
- Herpes Simplex, Prophylaxis (0 drugs)
- Herpes Simplex, Suppression (6 drugs)
Alternative treatments for Herpes Simplex
The following products are considered to be alternative treatments or natural remedies for Herpes Simplex. Their efficacy may not have been scientifically tested to the same degree as the drugs listed in the table above. However there may be historical, cultural or anecdotal evidence linking their use to the treatment of Herpes Simplex.
Legend
Off Label | This medication may not be approved by the FDA for the treatment of this condition. |
---|
Prescription Only / Over the Counter | |
---|---|
Rx | Prescription Only |
OTC | Over the Counter |
Rx/OTC | Prescription or Over the Counter |
Pregnancy | |
---|---|
A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
C | Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. |
N | FDA has not classified the drug. |
Controlled Substances Act Schedule | |
---|---|
N | Is not subject to the Controlled Substances Act. |
1 | Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. |
2 | Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
3 | Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
4 | Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
5 | Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
Alcohol | |
---|---|
X | Interacts with Alcohol. |